Viewing Study NCT00620620


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:30 AM
Study NCT ID: NCT00620620
Status: COMPLETED
Last Update Posted: 2017-03-14
First Post: 2008-02-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Staccato Zaleplon Single Dose Pharmacokinetics
Sponsor: Alexza Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-02
Start Date Type: None
Primary Completion Date: 2008-03
Primary Completion Date Type: ACTUAL
Completion Date: 2008-03
Completion Date Type: ACTUAL
First Submit Date: 2008-02-07
First Submit QC Date: None
Study First Post Date: 2008-02-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-03-13
Last Update Post Date: 2017-03-14
Last Update Post Date Type: ACTUAL